Obesity and related conditions and risk of inflammatory breast cancer: a nested case-control study.
Obesity and related conditions and risk of inflammatory breast cancer: a nested case-control study.
复制标题
DOI:
10.1007/s10549-020-05785-1
复制
发表时间:
2020-09
影响因子:
3.8
通讯作者:
Kushi LH
中科院分区:
文献类型:
--
作者:
Schairer C;Laurent CA;Moy LM;Gierach GL;Caporaso NE;Pfeiffer RM;Kushi LH
Inflammatory breast cancer (IBC) is a rare, poorly understood and aggressive tumor. We extended prior findings linking high body mass index (BMI) to substantial increased IBC risk by examining BMI associations before and after adjustment for well-characterized comorbidities using medical record data for diabetes, insulin resistance, and disturbances of cholesterol metabolism in a general community healthcare setting. We identified 247 incident IBC cases diagnosed at Kaiser Permanente Northern California between 2005–2017 and 2470 controls matched 10:1 on birth year and geographic area and with ≥13 months of continuous enrollment prior to diagnosis/index date. We assessed exposures from 6 years up to one year prior to the diagnosis/index date, using logistic regression to calculate odds ratios (ORs) with 95% confidence intervals (CIs). Before adjustment for comorbidities, ORs (95% CIs) for BMI of 25-<30, 30-<35, and ≥ 35 compared to <25 kg/m2 were 1.5 (0.9–2.3), 2.0 (1.2–3.1), and 2.5 (1.4–4.4), respectively. After adjustment for pre-diabetes/diabetes, HDL-C and triglyceride levels, and dyslipidemia, corresponding ORs were 1.3 (0.8–2.1), 1.6 (0.9–2.9), and 1.9 (1.0–3.5). The OR for HDL-C levels <50 mg/dL compared to ≥65 mg/dL was 2.0 (1.2–3.3) in the adjusted model. In a separate model the OR for a triglyceride/HDL-C ratio ≥2.50 compared to <1.62 was 1.7 (1.1–2.8) after adjustment for BMI, pre-diabetes/diabetes, and dyslipidemia. Results did not differ significantly by estrogen receptor status. Obesity and measures of insulin resistance independently increased IBC risk as did obesity and low HDL-C levels. These findings, if confirmed, have implications for IBC prevention.
登录
查看更多内容
影响因子:
16.2
作者:
Bullard KM;Saydah SH;Imperatore G;Cowie CC;Gregg EW;Geiss LS;Cheng YJ;Rolka DB;Williams DE;Caspersen CJ
通讯作者:
Caspersen CJ
影响因子:
10.3
作者:
Hance, KW;Anderson, WF;Levine, PH
通讯作者:
Levine, PH
影响因子:
5.6
作者:
Koebnick, Corinna;Smith, Ning;Kushi, Lawrence H.
通讯作者:
Kushi, Lawrence H.
影响因子:
5.5
作者:
Nichols GA;Desai J;Elston Lafata J;Lawrence JM;O'Connor PJ;Pathak RD;Raebel MA;Reid RJ;Selby JV;Silverman BG;Steiner JF;Stewart WF;Vupputuri S;Waitzfelder B;SUPREME-DM Study Group
通讯作者:
SUPREME-DM Study Group
影响因子:
11.5
作者:
Hostalek U;Gwilt M;Hildemann S
通讯作者:
Hildemann S